文献速递血栓与止血

患者与医疗提供者对参与产后静脉血栓栓塞预防试点试验的观点:一项定性研究

Patient and healthcare providers' perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: a qualitative study.
PubMed 文献 · J Thromb Haemost · 2025-03-12

该定性研究在单个加拿大中心对19例患者和13名医生进行半结构化访谈,探讨参与产后低剂量阿司匹林 vs 安慰剂试点试验(PARTUM)的促进与阻碍因素。患者认为研究设计简单和口服药物熟悉是参与促进因素,参与决策受静脉血栓栓塞风险感知、分娩体验和对产科照护者信任的影响。

要点

  • 患者认为研究设计简单和口服药物熟悉是参与试验的促进因素。
  • 患者参与决策受静脉血栓栓塞风险感知、分娩体验和对产科照护者信任的影响。
  • 试验参与独特地受到妊娠、分娩和新为人父母经历的影响。

核心结论

  • 试验参与独特地受到妊娠、分娩和新为人父母经历的影响。
  • 更好地理解对患者最重要的因素将为未来以患者为中心的临床试验的设计和实施提供信息。

研究设计与样本

  • 定性访谈研究,嵌套于低剂量阿司匹林 vs 安慰剂产后6周可行性试验(试点PARTUM试验)。
  • 邀请符合试点PARTUM试验条件的患者(包括拒绝参与试验者)及照护合格患者的医生参与。
  • 由2名研究者进行30分钟半结构化访谈,采用反思性主题分析迭代分析数据。
  • 在单个加拿大中心完成19例患者和13名医生访谈,包括9名试点PARTUM参与者和10名未参与者。

主要发现

  • 患者将简单的研究设计和熟悉的口服药物(「参与是容易的请求」)以及帮助其他父母(「通过提供知识帮助其他父母」)确定为参与试验的促进因素。
  • 大多数患者提及利他主义,但其参与试验的决定受静脉血栓栓塞风险感知(「静脉血栓栓塞风险感知与沟通」)、分娩体验(「分娩体验影响观点」)和对产科照护者看法(「吸引可信赖的照护提供者」)的影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a need to better understand barriers to recruitment and participation in randomized controlled trials evaluating postpartum thromboprophylaxis, as previous trials had low recruitment and were not feasible. OBJECTIVES: In a qualitative interview study of a feasibility trial of low-dose aspirin vs placebo for 6 weeks postpartum (pilot PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) trial), we explored the facilitators and barriers to trial involvement. METHODS: Patients eligible for the pilot PARTUM trial, including those who declined to join the trial, were invited to participate in a qualitative study. Physicians whose clinical practice included caring for eligible patients were also invited to participate. Thirty-minute semistructured interviews were conducted by 2 researchers. Data were analyzed iteratively using reflexive thematic analysis. RESULTS: There were 19 patients and 13 physician interviews conducted at a single Canadian center. Nine pilot PARTUM participants and 10 nonparticipants were included. Patients identified the simple study design and familiar oral medication ("Participating as an Easy Ask") and helping other parents ("Helping Other Parents by Providing Knowledge") as facilitators to participate in the trial. Most patients invoked altruism; however, their decision to participate in the trial was influenced by their perception of venous thromboembolism risk ("Venous Thromboembolism Risk Perception and Communication"), their birth experience ("Birth Experience Informs Perspective"), and their opinion of their obstetrical care provider ("Engaging Trusted Care Providers"). CONCLUSION: Trial participation is uniquely affected by experiences during pregnancy, delivery, and new parenthood. Improved understanding of the factors most important to patients will inform the design and conduct of future patient-focused clinical trials.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Andrew L, Garven A, Taylor TS, et al. Patient and healthcare providers' perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: a qualitative study. J Thromb Haemost. 2025. PMID: 40086753. doi:10.1016/j.jtha.2025.02.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。